Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

450 results about "Covalent binding" patented technology

Covalent bond, in chemistry, the interatomic linkage that results from the sharing of an electron pair between two atoms. The binding arises from the electrostatic attraction of their nuclei for the same electrons.

Bicyclic peptide ligands specific for nectin-4

The present invention relates to polypeptides which are covalently bound to molecular scaffolds such that two or more peptide loops are subtended between attachment points to the scaffold. In particular, the invention describes peptides which are high affinity binders of Nectin-4. The invention also includes drug conjugates comprising said peptides, conjugated to one or more effector and / or functional groups, to pharmaceutical compositions comprising said peptide ligands and drug conjugates and to the use of said peptide ligands and drug conjugates in preventing, suppressing or treating a disease or disorder mediated by Nectin-4.
Owner:BICYCLETX LTD

Multifunctional nano-enzyme platform as well as preparation method and application thereof

The invention belongs to the field of nano-drug preparations, and discloses a multifunctional nano-enzyme platform and a preparation method and application thereof, and the multifunctional nano-enzyme platform is mainly composed of a nano-enzyme, a carrier material and a targeting substance. The synthesis of the nano-enzyme, the loading of the nano-enzyme on a carrier material and the modification of a targeting substance on the surface of the nano-enzyme are carried out through methods such as stirring synthesis, coprecipitation, strong acid oxidation, chemical reduction, covalent binding, a solvothermal method and physical adsorption. The targeting substance on the surface of the nano-enzyme platform can be accurately and efficiently positioned to an inflammation part, the meta-acid microenvironment of the inflammation part enables the targeting substance and the carrier material to be subjected to structural depolymerization, so that various nano-enzymes are released, and the nano-enzymes not only realize self-cascade and synergistic catalysis enhancement effects of the enzymes at the inflammation part, but also can be used for preparing the nano-enzyme. And a substrate self-circulation catalysis system is also formed, so that the effect of efficiently relieving and treating various inflammation-related diseases is achieved.
Owner:ANHUI UNIV

Preparation method of degradable breathable antibacterial gloves

The invention relates to the technical field of preparation of antibacterial gloves, in particular to a preparation method of degradable breathable antibacterial gloves, and an emulsion formula of the degradable breathable antibacterial gloves comprises the following components in parts by weight: 100 parts of nitrile rubber modified polylactic acid, 5-10 parts of modified antibacterial filler, 1-3 parts of an anti-aging agent, 0.5-3 parts of a vulcanizing agent, 0.3-2 parts of a vulcanization accelerator and 0.5-1 part of a foaming agent. Through a high-molecular compound composition system, nitrile rubber modified polylactic acid, modified antibacterial filler and other components are compounded to prepare the glove with controllable degradability, lasting antibacterial property and good air permeability; on the basis of covalent binding of silicon dioxide loaded with antibacterial groups and modified chitosan, the synergistic antibacterial effect of the modified antibacterial filler is achieved, and therefore the antibacterial performance of the glove is improved.
Owner:SHANDONG INTE MEDICAL TECH CO LTD

Bicyclic peptide ligands specific for nectin-4

The present invention relates to polypeptides which are covalently bound to molecular scaffolds such that two or more peptide loops are subtended between attachment points to the scaffold. In particular, the invention describes peptides which are high affinity binders of Nectin-4. The invention also includes drug conjugates comprising said peptides, conjugated to one or more effector and / or functional groups, to pharmaceutical compositions comprising said peptide ligands and drug conjugates and to the use of said peptide ligands and drug conjugates in preventing, suppressing or treating a disease or disorder mediated by Nectin-4.
Owner:BICYCLETX LTD

Lipid nanoparticle with non-covalent bifunctional binders for active targeting

A nanoparticle complex comprises a bifunctional binder capable of non-covalently binding to the lipid nanoparticle in the nanoparticle complex.
Owner:MOTE THERAPEUTICS INC +1

Beta-lactoglobulin modified near-infrared fluorescent targeting probe as well as preparation method and application thereof

The invention discloses a beta-lactoglobulin modified near-infrared fluorescent targeting probe as well as a preparation method and application thereof. The probe comprises indocyanine green (ICG) and beta-lactoglobulin (beta-LG) which are covalently bound. Compared with the prior art, the probe disclosed by the invention has the advantages that (1) the probe disclosed by the invention improves the stability of the near-infrared fluorescent dye in a body and prolongs the retention time of the near-infrared fluorescent dye, so that the observation window time is prolonged, imaging information is fully acquired in real time, and the effective circulation time in the body is prolonged; (2) the probe has the advantages of good biocompatibility, low toxicity and the like; and (3) the probe can specifically enrich in renal tubules and perform targeted imaging in kidneys, so that diagnosis and treatment of kidney injury, especially acute injury, are realized.
Owner:JIANGSU UNIV OF SCI & TECH

Novel antifouling developing coating material as well as preparation method and application thereof

The invention provides a novel antifouling developing coating material and a preparation method and application thereof, the antifouling developing coating material has a structure as shown in formula I. In the structure of the antifouling developing coating material, platinum nanoparticles are connected with a modified phosphorylcholine polymer, and the modified phosphorylcholine polymer is partially used as an antifouling unit; and the platinum nanoparticles are used as developing units, so that the antifouling developing coating material has excellent antifouling performance and developing performance at the same time. The siloxane group in the antifouling unit can form covalent binding with the surface of the substrate, so that the coating is firmly bound on the substrate, the binding stability and safety of the antifouling developing coating material on the substrate are ensured, the antifouling developing coating material cannot be lost or fall off along with time lapse, the durability and reliability of the developing coating are remarkably improved, and the service life of the developing coating material is prolonged. Wide application prospects are realized.
Owner:SUZHOU SILVER MARS NEW MATERIALS TECHNOLOGY CO LTD

Method for detecting HCPs in biological protein medicine based on LC-MS / MS method

The invention discloses a method for detecting HCPs in a biological protein drug based on an LC-MS / MS method. The method comprises the following steps: covalently binding an HCPs-derived cell line protein sample and a monoclonal antibody protein with the sample by adopting a chemical reagent, mixing, fractionating, and finally performing liquid-phase mass spectrometry to obtain an analysis result of HCPs in the monoclonal antibody drug. Compared with the prior art, the detection signal is enhanced by adding the host cell protein for producing the monoclonal antibody, the detection sensitivity and the identification depth of low-abundance protein are remarkably improved, the important blank of HCPs analysis is filled up, and the monoclonal antibody can be used for detecting and proving HCPs removal, especially extremely-low-level hydrolase in drug process development, and can be applied to detection and proving of HCPs removal. The method has important influence on ensuring the quality of biological protein pharmaceutical products and the safety of patients.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES +1

Drug permeability clinical prediction model, construction method thereof and non-specific drug permeability evaluation method

The invention provides a drug permeability clinical prediction model, a construction method thereof and a non-specific drug permeability evaluation method, and belongs to the technical field of biological medicine. The invention provides a construction method of a drug permeability clinical prediction model. According to the construction method, intestinal microorganism characteristics are introduced into model construction for the first time. The prediction performance of the constructed LGBM model containing the intestinal microorganism characteristics in the aspect of NAC permeability prediction is superior to that of other traditional business models. The invention also provides a serine-derived sphingolipid de novo synthesis pathway, which is different from the traditional sphingolipid de novo synthesis pathway, and is named as a cysteine sphingolipid metabolism pathway, NAC-derived cysteine may participate in the biosynthesis of microbial sphingolipid through covalent binding with palmitoyl-CoA, thereby damaging intestinal permeation of NAC.
Owner:PEKING UNIVERSITY FIRST HOSPITAL (PEKING UNIVERSITY FIRST CLINICAL MEDICAL COLLEGE)

Gastrodia elata polypeptide extraction process

The invention discloses a gastrodia elata polypeptide extraction process, and belongs to the technical field of polypeptide extraction. According to the method, gastrodia elata cell membranes are broken through acetone pretreatment, so that protein and lipid are dissociated, trimethylsilyl ether passivates active groups, immobilized enzyme decomposes cellulose and adipose tissues through normal-temperature enzymolysis, a protein stabilizer prevents oxidation and inhibits enzyme activity, differential pressure extraction is combined with a sodium pyrophosphate buffer solution, polypeptide is promoted to be dissolved out, and activity is maintained; the high extraction rate of the gastrodia elata polypeptide and low-active group destructiveness are realized. Reaction sites and binding force are increased by epoxy groups on the surface of an immobilized enzyme carrier prepared by modifying corn starch, enzyme molecules are stable and appropriate due to good biocompatibility, enzyme molecule conformation is optimized through covalent binding, a rigid structure is enhanced, enzyme activity is kept at a high level for a long time, continuous and efficient enzymolysis is performed in gastrodia elata polypeptide extraction, and the gastrodia elata polypeptide extraction efficiency is improved. Compared with the traditional free enzyme, the gastrodia elata polypeptide enzyme has the advantages that the enzyme use cost is reduced, the enzyme consumption and waste generation are reduced, and an efficient and economical scheme is provided for gastrodia elata polypeptide extraction.
Owner:ZHEJIANG YINKAI BIOMEDICAL TECHNOLOGY CO LTD

Method for preparing protein-polyphenol covalent complex

The invention discloses a method for preparing a protein-polyphenol covalent complex, which comprises the following steps: firstly, treating a protein solution or turbid liquid by using low-temperature plasma, adding polyphenol into the treated protein solution to fully react, dialyzing the fully reacted polyphenol and protein mixed solution to remove the polyphenol which is not combined with the protein, and drying to obtain the protein-polyphenol covalent complex. And carrying out freeze drying to obtain the protein-polyphenol covalent complex. According to the method, no additive is added in the whole process, polyphenol oxidation is avoided, and the protein-polyphenol covalent binding compound can be rapidly and efficiently prepared.
Owner:SOUTH CHINA UNIV OF TECH

Method for enriching sulfydryl-containing peptide fragment based on covalent binding

The invention discloses a method for enriching a sulfydryl-containing peptide fragment based on covalent binding, in the method, a chemical reagent, namely 2-(2-pyridyl disulfide) ethylamine, capable of reacting with sulfydryl is used, the reagent comprises two functional reactive groups, specifically, amino and pyridyl disulfide, the amino can react with carboxyl magnetic beads, and the sulfydryl-containing peptide fragment can react with carboxyl magnetic beads. A novel pyridine disulfide-based magnetic bead material, namely the pyridine disulfide-based agar magnetic bead, is formed. According to the method, pyridine disulfide can directly react with the sulfydryl peptide fragment to form a covalent bond, so that the enrichment of the sulfydryl peptide fragment is realized, the sulfydryl peptide fragment can be eluted by adding a reducing agent such as DTT, and the method has the characteristics of low cost, good selectivity and the like.
Owner:HANGZHOU INST FOR ADVANCED STUDY UCAS

Antifouling developing coating material as well as preparation method and application thereof

The invention provides an antifouling developing coating material and a preparation method and application thereof.The antifouling developing coating material is of a structure shown in the formula I. The antifouling developing coating material combines antifouling and developing through a covalent binding technology, has excellent antifouling performance and developing performance, and can be applied to the field of chemical engineering. According to the invention, the stability and durability of the developing effect can be ensured, the safety is good, the application range is wider, and powerful support is provided for the safety of medical equipment and the accuracy of medical images.
Owner:SUZHOU SILVER MARS NEW MATERIALS TECHNOLOGY CO LTD

Preparation method and application of chitosan-casein peptide nanocomposite

The invention discloses a chitosan-casein peptide nano-particle and a preparation method and application thereof, and belongs to the technical field of food manufacturing, chitosan and casein peptide are combined into a nano-composite with the particle size of 10-1000 nm through electrostatic interaction in a non-covalent binding mode, and the nano-composite is used for preparing the chitosan-casein peptide nano-particle. A more stable oil-in-water emulsion can be prepared by utilizing the nano composite; the invention also provides a preparation method and application of the chitosan-casein peptide nanocomposite, and a preparation method of the oil-in-water emulsion. The nano-composite prepared by the invention has relatively strong oxidation resistance, foamability and foaming stability when the ratio of chitosan to casein peptide is 1: 1, and an oil-in-water emulsion prepared from the nano-composite has good storage stability, pH stability and ion stability. The preparation method of the nanocomposite is simple and low in cost, and has a good application prospect.
Owner:NORTHEAST AGRICULTURAL UNIVERSITY

Cross-linked modified artificial valve as well as preparation method and application thereof

The invention relates to the technical field of biomedicine, in particular to a cross-linked modified artificial valve and a preparation method and application thereof. The preparation method comprises the following steps: firstly, preparing a novel compound POSS-PEG-NHS, and carrying out esterification reaction on a-NHS group of the compound and a-NH2 group on the surface of the decellularized porcine valve to realize covalent binding; then, an inherent reducing agent glutathione in an organism is added, and the cross-linked modified artificial valve PPN-GSH-AV is obtained. The valve shows excellent cell safety and blood compatibility, and has obvious advantages compared with a traditional glutaraldehyde cross-linked valve. In-vivo experiments show that the PPN-GSH-AV has high biological safety and histocompatibility, and can effectively reduce immunological rejection. In addition, the valve can relieve oxidative stress of macrophages and promote M2 type transformation, so that inflammatory response is relieved. In clinical application, the PPN-GSH-AV shows a good anti-inflammatory effect and excellent anti-calcification performance, in-vitro pulsating flow test results meet international standards, and the PPN-GSH-AV has clinical transformation potential and wide application prospects.
Owner:ZHONGNAN HOSPITAL OF WUHAN UNIV +1

Charge-modified chitosan cross-linked encapsulant

An improved polyurea and chitosan core-shell delivery particle that encapsulates a benefit agent is described. Chitosan is pre-modified with a modifying compound, which is cationic, anionic or nonionic. Alternatively, modification is completed in situ. The modifying compound is selected from the group consisting of epoxides, aldehydes or alpha, beta-unsaturated compounds and reacts with the free amine moiety of the chitosan, covalently bound to the amine moiety of the chitosan via a CN bond. The modifying compound may contain an acidic group, a hydroxyl group, and a quaternary ammonium group. The reaction product of chitosan, a modifying compound, and an electrophile, preferably a polyisocyanate, produces microcapsules that have charge, improved release properties, improved compatibility, or enhanced degradation properties (e.g., in OECD Test Method 301B).
Owner:ENCAPSYS LLC

PAMAM-mediated labeled small molecule compound as well as synthesis method and application thereof

The invention belongs to the technical field of immunochemiluminescence, and relates to a PAMAM-mediated labeled small molecule compound and a synthesis method and application thereof.The PAMAM-mediated labeled small molecule compound is composed of small molecules, PAMAM and a marker, and the small molecules are provided with active groups or provided with derivative groups capable of reacting with amino under certain activation conditions to form covalent binding; the marker is provided with a succinimide group. The difference between a coupling product and a small molecular structure is reduced to the maximum extent through PAMAM mediation, the PAMAM dosage is extremely small and stable, compared with PEG, the molecular weight is more uniform, non-specific binding caused by hydrophobic interaction can be greatly reduced in immunoreaction, and good signals and separation can be obtained without purification of the product.
Owner:SUZHOU PIBOSI BIOTECHNOLOGY CO LTD

Preparation method and application of cyanine dye variants and cyanine protein composite fluorophores

The present invention is applicable to the technical field of near-infrared zone II imaging, provides a preparation method of a cyanine dye variant and a cyanine protein composite fluorophore, successfully prepares a series of cyanine dye-protein composite probes by using a protein encapsulation strategy, and forms a covalently bound complex by protein encapsulation and its application, wherein the covalently bound complex is formed by covalently linking a cyanine dye molecule and a protein; compared with the existing near-infrared zone II fluorescent probe, the composite of the present invention has better biocompatibility and luminescent behavior, a longer wavelength, good optical stability, high brightness, and superior imaging effect in fluorescent imaging applications.
Owner:JILIN UNIV FIRST HOSPITAL

Click type covalent drug and regioselective delivery system and application thereof

The invention discloses a click type covalent drug as well as a regioselective delivery system and application thereof. The click-type covalent drug delivery system comprises a click-type covalent drug and a tumor region selective delivery system, and the click-type covalent drug is composed of aza-cyclic alkyne (DBCO), a small molecule drug and a linker and has a structure as shown in a formula 1. Optionally, the small molecule drugs are membrane protein inhibitors, immunomodulators, chemotherapeutic drugs and the like. The click-type covalent drug and the azide-labeled target cell are subjected to a click reaction to form a covalent bond to be combined on a cell membrane, so that the local drug concentration is improved, the drug retention time is prolonged, and the selective inhibition on the target cell is enhanced; the regioselective delivery system is formed by co-assembling an amphiphilic block polymer and a click type covalent drug, and is used for regioselective delivery. By means of the click type covalent drug, covalent binding of azide-labeled tumor cells is achieved, normal cells which are not labeled by azide are not affected, and toxic and side effects on normal tissue are reduced. # imgabs0 #
Owner:EAST CHINA NORMAL UNIV +1

Bicyclic peptide ligands specific for NK cells

The present invention relates to polypeptides which are covalently bound to molecular scaffolds such that two or more peptide loops are subtended between attachment points to the scaffold. In particular, the invention describes peptides which bind to natural killer (NK) cells. The invention also includes multimeric binding complexes comprising at least two of said bicyclic peptide ligands. The invention also includes pharmaceutical compositions comprising said peptide ligands or said multimeric binding complexes and the use of said peptide ligands, multimeric binding complexes and pharmaceutical compositions in detecting diseases and disorders mediated by natural killer (NK) cells, and in preventing, suppressing or treating a disease or disorder mediated by natural killer (NK) cells, such as inflammatory disorders, autoimmune disease and cancer.
Owner:BICYCLETX LTD

Multifunctional tumor targeted low-temperature treatment nano platform and application thereof

ActiveCN119925626AOrganic active ingredientsEnergy modified materialsHeat Shock Protein InhibitorAptamer
The invention discloses a multifunctional tumor targeted low-temperature treatment nano platform and application thereof, and belongs to the technical field of nano biological medicines. According to the multifunctional tumor targeted low-temperature treatment nano platform, the two-dimensional Ti3C2 nano material serves as a carrier, indocyanine green is loaded to serve as a photosensitizer, polydopamine is modified on the surface to improve the stability, and gambogic acid is loaded to serve as an anti-tumor drug and a heat shock protein inhibitor; and a nucleic acid aptamer capable of recognizing specific protein on the cell surface is coupled in a covalent binding manner. The multifunctional tumor targeted low-temperature treatment nano platform is small in particle size, high in dispersion degree and good in biocompatibility, and shows excellent photo-thermal conversion capacity, photodynamic treatment effect and chemotherapy effect in tumor targeted treatment. The apoptosis of tumor cells can be effectively induced under a relatively low temperature condition, and the damage of high temperature to surrounding healthy tissues is remarkably reduced. The tumor focus specific recognition capability is also realized, the high enrichment at the tumor part can be realized, and the treatment effect is enhanced.
Owner:SHANXI DATONG UNIV

Magnetic nitrilase catalyst for green cyclic synthesis of organic acid as well as preparation method and application of magnetic nitrilase catalyst

The invention relates to the technical field of enzyme catalysis, relates to the technical field of bioengineering application, and in particular relates to a magnetic nitrilase catalyst for green cyclic synthesis of organic acid as well as a preparation method and application of the magnetic nitrilase catalyst. According to the method, nitrilase escherichia coli is fixed on a magnetic composite carrier in a covalent binding and adsorption-crosslinking manner to form a magnetic nitrilase catalyst, and the catalyst is used for catalytic synthesis of organic acid; after the reaction is finished, the magnetic nitrilase catalyst is recovered by magnetic attraction, and the reaction waste liquid is acidized to realize the purpose of green cyclic synthesis of the organic acid. The prepared magnetic nitrilase catalyst can stably exist in nitrile substances and has the advantages of being high in mechanical strength, low in enzyme activity loss rate and easy to store, the magnetic nitrilase catalyst and reaction liquid can be recycled, beneficial reference is provided for promoting clean, environment-friendly and efficient enzyme method production of organic acid, and the application prospect is wide. The method has huge application potential in continuous separation and industrial application.
Owner:ZHEJIANG UNIV OF TECH

Compounds with improved pharmacokinetics for imaging and therapy of cancer

The present invention relates to a compound binding to an endogenous receptor, said compound comprising (i) an oligopeptide comprising a dipeptide with Trp being the C-terminal amino acid of said dipeptide, wherein said Trp is replaced with an α-amino acid Xaa2, whereby the stability in serum or plasma of the peptide bond connecting Xaa2 to the N-terminally adjacent amino acid is increased as compared to the peptide bond connecting Trp to the N-terminally adjacent amino acid in an otherwise identical compound; and (ii) a moiety capable of generating therapeutically effective radiation, said moiety being covalently bound to said oligopeptide.
Owner:TECHNISCHE UNIVERSITAT MUNCHEN

Application of salvianolic acid A in preparation of medicine for preventing and treating advanced atherosclerosis vulnerable plaques

The invention discloses application of salvianolic acid A in preparation of a medicine for preventing and treating vulnerable plaques of advanced atherosclerosis. The invention also discloses application of the salvianolic acid A combined with ferulic acid or the salt thereof in preparation of drugs for preventing and treating advanced atherosclerosis vulnerable plaques. Researches find that salvianolic acid A can promote apoptosis of senescent vascular smooth muscle cells and has a Senlytics effect; the salvianolic acid A stabilizes vulnerable atherosclerotic plaques by reducing the load of senescent vascular smooth muscle cells; the salvianolic acid A is in non-covalent binding with ASP54, ALA55, LYS58, ASP93, ASP102 and LYS112 of the HSP90AA1 to play a role in inhibition, and the ASP93 has the greatest contribution to binding free energy. The research of the invention is of great significance to the development and application of drugs with anti-aging effect for stabilizing advanced atherosclerotic vulnerable plaques.
Owner:SHANDONG UNIV OF TRADITIONAL CHINESE MEDICINE

Ophthalmic devices containing localized grafted networks and processes for their preparation and use

ActiveUS12391789B2Optical articlesOptical partsSubstrate networkCross linker
Provided are polymer compositions made by a process comprising: (a) providing a first reactive composition containing: (i) a polymerization initiator that is capable, upon a first activation, of forming two or more free radical groups, at least one of which is further activatable by subsequent activation; (ii) one or more ethylenically unsaturated compounds; and (iii) a crosslinker; (b) subjecting the first reactive composition to a first activation step such that the first reactive composition polymerizes therein to form a crosslinked substrate network containing a covalently bound activatable free radical initiator; (c) contacting the crosslinked substrate network with a grafting composition containing one or more ethylenically unsaturated compounds, wherein the contacting is conducted under conditions such that the grafting composition penetrates into the crosslinked substrate network; and (d) activating the covalently bound activatable free radical initiator at one or more selective regions of the crosslinked substrate network such that the grafting composition polymerizes with the crosslinked substrate network at the selective regions.
Owner:JOHNSON & JOHNSON VISION CARE INC

Electrochemical biosensor for detecting mycobacterium tuberculosis

The invention discloses an electrochemical biosensor for detecting mycobacterium tuberculosis. The sensor takes a porous membrane as a base material, the inner wall of a pore channel of the porous membrane is co-modified with a polydopamine (PDA) and conductive carbon material composite layer, and an amino-modified specific capture probe based on a mycobacterium tuberculosis ESAT-6 gene is fixed on a modification layer through covalent binding. When a target gene is captured by a probe, the volume effect of the target gene causes blockage of a porous channel of the porous membrane, so that electrochemical signals (such as current) of the sensor are changed, and high-sensitivity and specific detection of mycobacterium tuberculosis is realized. According to the invention, a porous structure, biological probe specific fixation and an electrochemical signal conversion technology are combined, and a novel efficient tool is provided for rapid diagnosis of tuberculosis.
Owner:TIANJIN SAIDE MEDICAL INSTR CO LTD

Amphiphilic sizing agent suitable for glass fiber / resin composite material

The invention discloses an amphiphilic sizing agent suitable for a glass fiber / resin composite material, which is prepared by polymerizing glycidyl methacrylate and methacrylic acid ethyl trimethyl ammonium chloride by a reversible addition-fragmentation chain transfer polymerization method to form glycidyl ester-ethyl trimethyl ammonium chloride; and introducing dopamine methacrylamide by using a free radical polymerization technology to obtain the amphiphilic sizing agent. The amphiphilic sizing agent can be applied to the surface of the glass fiber without being filled with a plasticizer, a coupling agent, an inhibitor and the like, the coating performance and the binding performance of a product can be adjusted by changing the proportion of structural units, and the amphiphilic sizing agent can form a covalent binding effect with hydroxyl on the glass fiber through epoxy; positive charges and negative charges on the surface of the glass fiber can form electrostatic interaction combination, and dopamine groups and groups on the resin can form powerful hydrogen-bond interaction, so that efficient load transfer is realized.
Owner:NINGBO WEICHUANG FLEXIBLE ELECTRONIC TECH CO LTD +2

A multifunctional nanozyme platform and its preparation method and application

The present invention belongs to the field of nano drug preparations, and discloses a multifunctional nanozyme platform and its preparation method and application, which is mainly composed of nanozymes, carrier materials and targeting substances. The synthesis of nanozymes, the loading of nanozymes on carrier materials and the modification of their surface targeting substances are carried out by methods such as stirring synthesis, coprecipitation, strong acid oxidation, chemical reduction, covalent bonding, solvent thermal method, physical adsorption, etc. The targeting substance on the surface of the nanozyme platform can be accurately and efficiently positioned to the inflammation site, and the acidic microenvironment of the inflammation site causes the targeting substance and the carrier material to undergo structural depolymerization, thereby releasing a variety of nanozymes, which not only realize the self-cascade and synergistic catalytic enhancement of enzymes at the inflammation site, but also form a substrate self-circulation catalytic system, thereby achieving the effect of efficiently alleviating and treating various inflammation-related diseases.
Owner:ANHUI UNIV

Cancer-associated protein-targeted strong or covalently binding precursor compounds and radiotracers

A precursor compound and a radioligand for cancer diagnosis and treatment comprises a high-affinity ligand PL for a cancer- associated protein conjugated to a covalent warhead CW for strong or covalent binding to an amino acid sidechain of the cancer-associated protein and a chelator Ch for complexation of a radioisotope or a leaving group LR for substitution with a radioisotope, wherein the covalent warhead CW is configured for quasi-covalent ionic binding using a sulfonic acid group or for covalent binding using a sulfur fluoride exchange (SuFEx) group, a benzotriazole or N-methyl-N- arylmethanesulfonamide leaving group or a malolactone group for strain-release alkylation.
Owner:ZOUNEK ALEXIS NIKOLAI +1

Human serum albumin covalent binding type targeted folate receptor micromolecule drug conjugate prodrug and application thereof

The invention belongs to the field of biological medicine, and relates to a human serum albumin covalent binding type targeted folate receptor micromolecule drug conjugate prodrug and application thereof. The prodrug disclosed by the invention has a structure as shown in a formula I, six-carbon maleimide is used as a site combined with endogenous albumin, and albumin is used as a carrier to deliver the drug. The prodrug can increase accumulation of the drug in tumors under the EPR effect. A dipeptide chain composed of valine and alanine is used as a cleavage site of cathepsin B, an adapter composed of p-aminobenzyl ether and N-methylamino-4-nitrophenol releases drugs in an acidic environment, an azidohexanoic acid structure is added to a side chain of p-aminobenzyl ether, so that the site of a targeting ligand can be increased, and SN38 is used as a small molecule cytotoxic load. The micromolecular prodrug has dual functions of active targeting and passive targeting, and can effectively improve the concentration in solid tumors, reduce toxic and side effects and improve the anti-tumor effect under the mediation of related receptors.
Owner:EAST CHINA NORMAL UNIV